Like any other businesses, StemLife was just a small company when it first started in 2001 and became the pioneer in the cord blood banking industry.

Although cord blood banking was still a new thing back then, StemLife has managed to beat the odds by thriving in this niche industry over the past years.

StemLife is Malaysia’s first fully licensed cord blood stem cell banking service provider and has achieved a number of recognitions through awards and certifications.

Check out StemLife’s journey below!



  • Incorporation of StemLife Sdn Bhd
  • 1st Umbilical Cord Blood Stem Cells (UCBSC) unit collected and stored
  • Expanded nationwide
  • 1st overseas UCBSC unit
  • Co-founded Asia Pacific Cord Blood Bank Consortium (APCBBC)
  • Profit achieved (after only 3 years of operation)
  • 1st UCBSC unit released for transplant - AML (Acute Myeloid Leukaemia) and the 1st in the country to use stem cells stored with a private bank
  • Incorporation of ThaiStemLife
  • Launch of StemLife Therapeutics Sdn. Bhd. for Peripheral Blood Stem Cells (PBSC) service in May.
  • 5,000 total cumulative UCBSC units stored


  • Listed on the MESDAQ board, change of status to StemLife Berhad
  • Technology Business Review Award - Excellence in biotechnology for stem cell medical application
  • Deloitte Technology Fast 500 Asia Pacific Award
  • Relocated laboratory to a bigger facility in the heart of Kuala Lumpur
  • Launch of StemLife Logistics Sdn Bhd to provide end-to-end comprehensive Logistics service with a fleet of acquired logistics vehicles.
  • Publication of 3 research papers on bone cell growth with nanofiber technology in international journals in conjunction with NUSNNI
  • Technology Business Review Award - Excellence in biotechnology for stem cell medical application
  • BioNexus Status awarded by Bioeconomy Corporation (Formerly known as Malaysian Biotechnology Corporation)
  • Launch of new 'benefit services' for clients -StemAssured, Stem21
  • Inaugural public stem cell seminar featuring world renown cord blood stem cell expert Prof. Dr. Colin McGuckin, Professor of Regenerative Medicine, Newcastle University, UK
  • PHFS Act 1998 License (under Ministry of Health) awarded to StemLife for UCBSC banking
  • Launch of new 'benefit service' for clients - StemShield
  • Brandlaureate Master Award (Stem Cell Banking)
  • Launch of new 'benefit service' for clients - StemCourier, StemShieldPLUS
  • 32,000 total cumulative UCBSC units stored
  • Frost & Sullivan Malaysia Excellence Award in Growth Leadership - Stemcell banking and therapeutics
  • StemLife Laboratory accredited with MS ISO 15189


  • Frost & Sullivan Malaysia Excellence Award in Growth Leadership - Healthcare biotech company of the year
  • Affiliation to Cordlife group in Singapore, Hong Kong, Macau, Indonesia, India and Philippines
  • Quality Choice Company of The Year in Stem Cell
  • Category awarded by EU Analysis Alliance
  • Global Leadership Awards Excellence in Stem Cell Technology awarded by The Leaders International Business Magazine
  • Launch of new service for clients -Cord Tissue Banking
  • StemLife Laboratory re-accredited MS IS0 15189
  • StemLife Berhad became a subsidiary of Cordlife Group Limited
  • StemLife collaborates with Jerudong Park Medical Centre (JPMC) to offer cord blood banking services to the Brunei market.
  • Frost & Sullivan Malaysia Excellence Award 2017 - Malaysia Stem Cell Banking Company of the Year
Milestones 2018


  • StemLife launched its first diagnostic product called Metascreen, which offers newborn metabolic screening.
  • StemLife receives the first World-class AABB Accreditation
  • 1st UCBSC unit released for Autism Spectrum Disorder (clinical trial)
  • StemLife Berhad opens Stem Cell banking Resource Centre in JPMC.
  • StemLife received the first AABB re-accreditation
  • StemLife launched its second diagnostic product called Non-Invasive Prenatal Testing (NIPT).
  • StemLife launched its first app called Moms Up App for mothers at the conceiving, expecting and parenting stage in motherhood.
  • BrandLaureate World’s e-Branding Award – Best Brand of the Year 2020 in Innovation Stem Cell Solutions.
  • StemLife launched its third diagnostic product called Bebegene - Newborn Genetic Screening.
  • More than 65,000 total cumulative UCBSC units stored
  • StemLife received the second AABB re-accreditation